
News|Articles|January 1, 2009
First-time generic drug approvals, January 2009
Generic drugs approved by FDA (through January 2009) including rocuronium injection and budesonide inhalation suspension
Advertisement
Rocuronium injection, 50 mg/5 mL (equiv to Zemuron injection)
GENERAMEDIX, HOSPIRA, TEVA
Budesonide inhalation suspension, 0.25 mg/2 mL and 0.5 mg/2 mL (equiv to Pulmicort Respules)
TEVA
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
Researchers discover new pathway to fight liver inflammation
4
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
5





















